MK Biotech Revolution
MAKER
Letzter Login: 25.02.2021
Performance
-
-1,6 %seit 09.12.2020
-
-1 Jahr
-
-Ø-Performance pro Jahr
Risiko
-
-20,2 %Max Verlust (bisher)
-
0,81×Risiko-Faktor
Handelsidee
Companies within this Wikifolio shall be focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies shall be held in this Wikifolio may develop, produce or enable:
CRISPR
Targeted Therapeutics
Bioinformatics
Molecular Diagnostics
Stem Cells
Agricultural Biology
Decisions to invest will be based on fundamental criteria as well as chart analysis. mehr anzeigen
CRISPR
Targeted Therapeutics
Bioinformatics
Molecular Diagnostics
Stem Cells
Agricultural Biology
Decisions to invest will be based on fundamental criteria as well as chart analysis. mehr anzeigen
Dieser Inhalt ist in der aktuellen Sprache nicht verfügbar.
Stammdaten
Symbol
|
WFGENEREVO |
Erstellungsdatum
|
09.12.2020 |
Indexstand | |
High Watermark
|
120,5 |